SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Politics : Formerly About Advanced Micro Devices

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Wharf Rat who wrote (851295)4/21/2015 12:52:18 AM
From: i-node  Read Replies (1) of 1579459
 
>> Not even. You can see how often they were right from this study.

OMG. You are utterly clueless. Radical mastectomy was all but discontinued as a result of this study and several others like it. And that is the problem: You people jump on bandwagons without having any idea WTF you're talking about.

These surgeries left women seriously injured from the surgery. No one would think it is a credible treatment for small tumors of the breast today.

It was wrong, wrong, wrong. I would think you would have known that.

CONCLUSIONS: The findings validate earlier results showing no advantage from radical mastectomy. Although differences of a few percentage points cannot be excluded, the findings fail to show a significant survival advantage from removing occult positive nodes at the time of initial surgery or from radiation therapy.

ncbi.nlm.nih.gov

ncbi.nlm.nih.gov
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext